Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.6%

81 terminated/withdrawn out of 844 trials

Success Rate

83.6%

-2.9% vs industry average

Late-Stage Pipeline

9%

73 trials in Phase 3/4

Results Transparency

38%

155 of 412 completed trials have results

Key Signals

124 recruiting155 with results47 terminated34 withdrawn

Enrollment Performance

Analytics

N/A
402(59.8%)
Phase 2
91(13.5%)
Phase 1
71(10.6%)
Phase 3
37(5.5%)
Phase 4
36(5.4%)
Early Phase 1
35(5.2%)
672Total
N/A(402)
Phase 2(91)
Phase 1(71)
Phase 3(37)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (844)

Showing 20 of 844 trials
NCT06599229Active Not Recruiting

Perfusion Abnormalities in Hypertrophic Cardiomyopathy

Role: lead

NCT05624125Not ApplicableRecruiting

BEETroot Juice to Reverse Functional Impairment in PAD

Role: collaborator

NCT05195918Phase 1Completed

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Role: collaborator

NCT05550896Active Not Recruiting

Platelet Adhesion in the Pathobiology of Aortic Stenosis

Role: lead

NCT07227051Not ApplicableRecruiting

Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity

Role: collaborator

NCT07322302Not ApplicableRecruiting

RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

Role: collaborator

NCT05478707Phase 2Suspended

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

Role: lead

NCT03707431Not ApplicableCompleted

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Role: collaborator

NCT06907173Phase 3Recruiting

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Role: lead

NCT07010146Phase 2Recruiting

Role of Estrogen on Skeletal Outcomes in FHA

Role: lead

NCT05321342Not ApplicableCompleted

Coaching Teachers in Bullying Detection and Intervention

Role: collaborator

NCT06248606Phase 2Recruiting

Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases

Role: collaborator

NCT06324929Not ApplicableActive Not Recruiting

Optimizing a Digital AEP Risk Intervention With Native Women and Communities

Role: lead

NCT01905865Completed

The Role of Uncertainty in Coping: The Experience of Parents of Children With Undiagnosed Medical Conditions

Role: collaborator

NCT04716452Phase 1Recruiting

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Role: collaborator

NCT06903923Recruiting

Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy

Role: lead

NCT07292389Not ApplicableRecruiting

Examining Valence-based Effects in Self-Monitoring Feedback Messages

Role: lead

NCT06110273Not ApplicableActive Not Recruiting

Fit for Duty: mHealth Intervention for Weight Gain Prevention

Role: collaborator

NCT06556810Phase 1Active Not Recruiting

IC14 for Treatment of Acute Decompensated Heart Failure

Role: collaborator

NCT06678074Phase 1Active Not Recruiting

Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI

Role: collaborator